Clinical Trials Related to AstraZeneca

Related studies linked through entity extraction aliases.

To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours

Status: COMPLETED
Phase: PHASE1

Dyslipidemia Management in Chinese Post Stroke Patients

Status: COMPLETED
Phase: N/A

Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

Status: COMPLETED
Phase: PHASE1

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Status: COMPLETED
Phase: PHASE1

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Status: COMPLETED
Phase: PHASE1

Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069

Status: COMPLETED
Phase: PHASE1

Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Status: COMPLETED
Phase: PHASE1

Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention

Status: COMPLETED
Phase: N/A

Risk of Uncomplicated Peptic Ulcer in the General Population

Status: COMPLETED
Phase: N/A

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

Status: COMPLETED
Phase: N/A

Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial

Status: COMPLETED
Phase: N/A

Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

Status: COMPLETED
Phase: PHASE1

Studying the Effects of Phentermine on Eating Behavior

Status: COMPLETED
Phase: PHASE4

AZD8186 First Time In Patient Ascending Dose Study

Status: COMPLETED
Phase: PHASE1

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Status: COMPLETED
Phase: PHASE3

An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus

Status: COMPLETED
Phase: PHASE3

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction

Status: COMPLETED
Phase: NA

Bioequivalence Study

Status: COMPLETED
Phase: PHASE1

A Study of AZD4901 in Females With Polycystic Ovary Syndrome

Status: COMPLETED
Phase: PHASE2